A carregar...
Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma
Survival for patients with multiple myeloma has significantly improved in the last decade in large part due to the development of proteasome inhibitors and immunomodulatory drugs. These next generation agents with novel mechanisms of action as well as targeted therapies are being used both in the pr...
Na minha lista:
| Publicado no: | Clin J Am Soc Nephrol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Nephrology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5220662/ https://ncbi.nlm.nih.gov/pubmed/27654928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.06100616 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|